Why it’s a good year for diagnostics startups
Venture capitalists have typically shied away from investing in diagnostics. That mentality has changed, and a GE Ventures executive explains why.
Illumina embarks on its own next-gen journey
With a new tumor profiling panel, Illumina continues its transformation from a research tools provider to a genetic healthcare company.
Solera Health’s Playbook To Beat Rising Employer Expenses
Solera Health is working to streamline employer contracting with health tech.